We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-1.81%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5.56B
AUM Growth
+$94.2M
(+1.7%)
Cap. Flow
+$293M
Cap. Flow
% of AUM
5.28%
Top 10 Holdings %
Top 10 Hldgs %
35.79%
Holding
4,002
New
390
Increased
2,050
Reduced
771
Closed
169
Avg Time Held Equity + Options
4.8
years
Top 10 Avg Time Held Equity + Options
3.5
years
Top 20 Avg Time Held Equity + Options
4.4
years
Avg Time Held Equity only
4.8
years
Top 10 Avg Time Held Equity only
3.5
years
Top 20 Avg Time Held Equity only
4.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$160M |
| 2 |
Avantis Emerging Markets Equity ETF
AVEM
|
+$59.5M |
| 3 |
VictoryShares Free Cash Flow ETF
VFLO
|
+$57M |
| 4 |
JPMorgan International Bond Opportunities ETF
JPIB
|
+$43M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$19.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$180M |
| 2 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$51M |
| 3 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$3.59M |
| 4 |
CVB Financial
CVBF
|
+$3.2M |
| 5 |
iShares International Select Dividend ETF
IDV
|
+$3.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 50.36% |
| 2 | Technology | 16.32% |
| 3 | Healthcare | 6.92% |
| 4 | Financials | 6.46% |
| 5 | Communication Services | 5.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3726
Tilray
TLRY
$477M
| $162 | ﹤0.01% |
25
| – | – |
2018 Q3
30 quarters
|
|
3727
Heron Therapeutics
HRTX
$71.3M
| $160 | ﹤0.01% |
200
| – | – |
2020 Q1
24 quarters
|
|
3728
Savers
SVV
$1.56B
| $156 | ﹤0.01% |
21
-63
| -75% | -$602 |
2024 Q4
5 quarters
|
|
3729
Wheels Up
UP
$122M
| $155 | ﹤0.01% |
15
| – | – |
2025 Q3
2 quarters
|
|
3730
EverQuote
EVER
$741M
| $154 | ﹤0.01% |
10
-62
| -86% | -$1.17K |
2024 Q1
8 quarters
|
|
3731
MBIA
MBI
$225M
| $154 | ﹤0.01% |
26
| – | – |
2023 Q4
9 quarters
|
|
3732
Camtek
CAMT
$5.94B
| $152 | ﹤0.01% |
+1
| New | +$152 |
2026 Q1
0 quarters
|
|
3733
John Wiley & Sons Class A
WLY
$2.68B
| $152 | ﹤0.01% |
4
-175
| -98% | -$5.67K |
2019 Q4
25 quarters
|
|
3734
Patria Investments
PAX
$1.91B
| $151 | ﹤0.01% |
12
| – | – |
2024 Q4
5 quarters
|
|
3735
ThredUp
TDUP
$309M
| $151 | ﹤0.01% |
46
| – | – |
2023 Q1
12 quarters
|
|
3736
Editas Medicine
EDIT
$367M
| $148 | ﹤0.01% |
60
| – | – |
2022 Q2
15 quarters
|
|
3737
Avita Medical
RCEL
$411M
| $148 | ﹤0.01% |
40
| – | – |
2021 Q1
20 quarters
|
|
3738
Transcat
TRNS
$768M
| $147 | ﹤0.01% |
+2
| New | +$141 |
2026 Q1
0 quarters
|
|
3739
Amarin Corp
AMRN
$245M
| $145 | ﹤0.01% |
10
| – | – |
2018 Q4
29 quarters
|
|
3740
Community Health Systems
CYH
$420M
| $144 | ﹤0.01% |
49
| – | – |
2025 Q4
1 quarter
|
|
3741
Alight
ALIT
$239M
| $143 | ﹤0.01% |
12
-134
| -92% | -$3.19K |
2022 Q2
15 quarters
|
|
3742
iShares Future Exponential Technologies ETF
XT
$3.97B
| $136 | ﹤0.01% |
2
| – | – |
2025 Q2
3 quarters
|
|
3743
Cronos Group
CRON
$1.19B
| $128 | ﹤0.01% |
51
+50
| +5,000% | +$130 |
2022 Q1
16 quarters
|
|
3744
Generation Income Properties
GIPR
$1.22M
| $128 | ﹤0.01% |
50
| – | – |
2022 Q3
14 quarters
|
|
3745
BlackRock Enhanced Captial and Income Fund
CII
$1.03B
| $126 | ﹤0.01% |
+6
| New | +$135 |
2026 Q1
0 quarters
|
|
3746
Passage Bio
PASG
$12.5M
| $126 | ﹤0.01% |
16
| – | – |
2025 Q3
2 quarters
|
|
3747
Altimmune
ALT
$453M
| $123 | ﹤0.01% |
40
| – | – |
2021 Q1
20 quarters
|
|
|
AXIA.PR
3748
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
| $113 | ﹤0.01% |
+9
| New | +$105 |
2026 Q1
0 quarters
|
|
3749
ARK Autonomous Technology & Robotics ETF
ARKQ
$1.8B
| $112 | ﹤0.01% |
1
| – | – |
2025 Q4
1 quarter
|
|
3750
Wolfspeed
WOLF
$1.33B
| $98 | ﹤0.01% |
6
+2
| +50% | +$36 |
2020 Q1
24 quarters
|
|
Similar funds
Parallel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Parallel Advisors held 4,002 positions worth $5.56B, up 1.7% from $5.47B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Parallel Advisors deployed $293M of net new capital in Q1 2026, opening 390 new positions and adding to 2,050 existing holdings. Its largest new stake was JPMorgan International Bond Opportunities ETF: 883,008 shares worth $42.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, up from 48% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Core S&P Total US Stock Market ETF, an estimated $180M trimmed.
- Parallel Advisors's largest Q1 2026 buy was JPMorgan International Bond Opportunities ETF: 883,008 shares worth $42.2M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $160M increase.
- Parallel Advisors's biggest Q1 2026 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $180M.
- Parallel Advisors fully exited iShares 1-3 Year International Treasury Bond ETF in Q1 2026, selling an estimated $741K.
- Parallel Advisors's ten largest holdings make up 36% of its $5.56B portfolio in Q1 2026.
- Parallel Advisors opened 390 new positions and closed 169 in Q1 2026.
- Parallel Advisors's portfolio value rose 1.7% quarter-over-quarter to $5.56B.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.